These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 3923162
21. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology]. Cordonnier D, Vert-Pré FC, Bayle F, Alix JL, Couderc P. Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381 [Abstract] [Full Text] [Related]
29. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma. Waldhorn RE, Tsou E, Smith FP, Kerwin DM. Med Pediatr Oncol; 1984 Mar; 12(6):394-6. PubMed ID: 6548790 [Abstract] [Full Text] [Related]
30. 5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary. van der Gaast A, Verweij J, Planting AS, Stoter G. Eur J Cancer Clin Oncol; 1988 Apr; 24(4):765-8. PubMed ID: 3383976 [Abstract] [Full Text] [Related]
31. Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma. Crocker J, Jones EL. J Clin Pathol; 1983 Jan; 36(1):24-9. PubMed ID: 6401771 [Abstract] [Full Text] [Related]
32. Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin. Chow S, Roscoe J, Cattran DC. Am J Kidney Dis; 1986 May; 7(5):407-12. PubMed ID: 3085480 [Abstract] [Full Text] [Related]
33. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature]. Nicolás JM, Villalta J, González-Clemente JM, Antúnez E, Almirall J, Bosch J, Torras A, Urbano-Márquez A. Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657 [Abstract] [Full Text] [Related]
34. Recovery from mitomycin C-induced hemolytic uremic syndrome. A case report. Verwey J, Boven E, van der Meulen J, Pinedo HM. Cancer; 1984 Dec 15; 54(12):2878-81. PubMed ID: 6437662 [Abstract] [Full Text] [Related]
35. Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C. Desablens B, Fievet P, Pruna A, Claisse JF, Westeel PF, Tolani M, Fournier A. Nephron; 1986 Dec 15; 42(4):343-4. PubMed ID: 3083278 [No Abstract] [Full Text] [Related]
39. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case]. Deme D, Ragán M, Kalmár K, Kovács L, Varga E, Varga T, Rakonczai E. Magy Onkol; 2010 Dec 15; 54(4):351-7. PubMed ID: 21163766 [Abstract] [Full Text] [Related]
40. Mitomycin-C induced hemolytic uremic syndrome: a case report. Gundappa RK, Sud K, Kohli HS, Gupta KL, Joshi K, Sakhuja V. Ren Fail; 2002 May 15; 24(3):373-7. PubMed ID: 12166705 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]